Surgeons continue to request devices that use muscle- and tissue-sparing techniques that return patients to activity faster and with less pain. These requests are largely driven by patients in the segment, such as athletes and “weekend warriors,” who are making more decisions about their care. These requests, in turn, continue to grow the arthroscopy and soft tissue market.

ORTHOPRENEUR spoke with four device companies, ranging from early-stage to large player, that are responding to this trend in a number of ways. Some are launching and refining diverse product portfolios to cover a range of procedures, while others focus on meeting specific clinical needs. Surgeons and companies say that some biologics and stem cells are gaining greater traction as potential treatment options, as well.